Strengthening the Earnings Base Through Domestic and Overseas Capital Investment
First written in FY2016. 21 of 22 entries say "Advanced", first in FY2017. Latest entry: FY2026.
126 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「The group made total capital investments of ¥54,004 million during the consolidated fiscal year. This amount excludes consumption tax and other taxes. Major projects included construction of new cogeneration facilities at the Takasago Works and construction of a medical-device plant by カネカメディックス.」
Annual capital investment totaled ¥54,004 million, with continued investment in cogeneration facilities at Takasago, a medical-device plant, Green Planet facilities and electronic-materials facilities. Capacity expansion plans scheduled for completion in 2027 through 2028 were also presented. - 2026-05-14AdvancedEarnings
「We will actively promote investment to accelerate growth in the Life Sciences and Advanced Businesses and expedite transformation of the business portfolio.」
The company recorded ¥54,004 million in acquisitions of property, plant and equipment and intangible assets, explicitly indicating continued investment in the Life Sciences and Advanced Businesses and portfolio transformation. - FY2025-H1AdvancedAnnual report
「Net cash used in investing activities was ¥30,432 million, mainly due to payments for the acquisition of property, plant and equipment, down ¥209 million year on year.」
The company spent ¥30,432 million in the interim period on the acquisition of property, plant and equipment and other items and continued capital investment. - FY2024-Q3AdvancedAnnual report
「Total assets at the end of the third quarter of the current consolidated fiscal year increased by ¥67,980 million from the end of the previous consolidated fiscal year to ¥850,620 million. The increase was due to higher inventories, increases in fixed assets resulting from expanded capital investment, and increases in the value of overseas group companies’ assets caused by the weaker yen.」
The disclosure identifies increases in fixed assets resulting from expanded capital investment as a factor behind the increase in total assets, with continued investment in the domestic and overseas earnings base reflected in the financial position. - FY2024-Q2AdvancedAnnual report
「Net cash used in investing activities was ¥30,642 million, mainly due to payments for the acquisition of property, plant and equipment, up ¥9,666 million year on year.」
Investing-activity outflows for the first six months totaled ¥30,642 million, including ¥28,466 million in payments for the acquisition of property, plant and equipment, representing capital investment above the level of the same period of the previous year. - FY2023AdvancedAnnual report
「The group has invested in Japan and overseas to strengthen its earnings base over the medium to long term, and made total capital investments of ¥44,348 million during the consolidated fiscal year. This amount excludes consumption tax and other taxes.」
The company continued capital investment in its domestic and overseas earnings base, bringing annual investment to ¥44,348 million. Investment continued in advanced and new businesses and production infrastructure, including Green Planet, a medical-device plant and wastewater treatment facilities. - FY2023-Q3AdvancedAnnual report
「Total assets at the end of the third quarter of the current consolidated fiscal year increased by ¥61,726 million from the end of the previous consolidated fiscal year to ¥788,686 million. This was due to increases in accounts receivable and inventories accompanying higher sales, as well as increases in property, plant and equipment resulting from expanded capital investment.」
Total assets at the end of the third quarter increased by ¥61,726 million from the end of the previous fiscal year, with continued investment including increases in property, plant and equipment resulting from expanded capital investment. - FY2023-Q2AdvancedAnnual report
「Net cash used in investing activities during the first six months of the current consolidated cumulative period was ¥20,975 million, up ¥4,067 million year on year. The main component was ¥19,979 million in payments for the acquisition of property, plant and equipment.」
Payments for the acquisition of property, plant and equipment totaled ¥19,979 million in the first half, representing capital investment above the level of the same period of the previous year. - FY2023-Q1AdvancedAnnual report
「The company decided to increase production capacity for resin used in acrylic film, as demand is expected to continue expanding.」
The company decided to increase production capacity for resin used in acrylic film for large-screen televisions, for which demand is expected to expand. - FY2022-Q3AdvancedAnnual report
「The Group has decided on large-scale capital investments in advanced and new businesses to further accelerate transformation of its business portfolio. ① Large-scale capacity expansion for biodegradable polymer Green Planet (Investment: approximately ¥15 billion; 15,000 tonnes per year; operations scheduled to begin in January 2024) ② Construction of a new medical device plant in Hokkaido (Investment: approximately ¥10 billion; operations scheduled to begin in May 2024)」
As major capital investments in advanced and new businesses, the company decided to expand Green Planet capacity by 15,000 tonnes per year and construct a new medical-device plant in Hokkaido. - FY2022-Q2AdvancedAnnual report
「Net cash used in investing activities during the first six months of the current consolidated cumulative period was ¥16,908 million, down ¥5,857 million year on year. The main component was ¥16,893 million in payments for the acquisition of property, plant and equipment.」
The company spent ¥16,893 million on the acquisition of property, plant and equipment in the first half and continued capital investment in its domestic and overseas earnings base. - FY2021AdvancedAnnual report
「The group’s planned investments in new and expanded major facilities as of the end of the current consolidated fiscal year are as follows.」
In addition to making ¥38,949 million in capital investments, the company planned to complete the cogeneration equipment upgrade at the Takasago Works in December 2022 and the expansion of electronic-materials production facilities at the Shiga Plant in March 2022. - FY2021-Q1AdvancedAnnual report
「The company decided to increase the capacity of its Vietnam plant to three times the current level.」
The company is moving toward a decision to increase the capacity of its Vietnam plant to three times the current level. - FY2020-Q2AdvancedAnnual report
「Net cash used in investing activities during the first six months of the current consolidated cumulative period was ¥20,920 million, down ¥1,083 million year on year. The main component was ¥23,745 million in payments for the acquisition of property, plant and equipment.」
The company spent ¥23,745 million on the acquisition of property, plant and equipment in the first half and continued capital investment in its domestic and overseas earnings base. - FY2019AdvancedAnnual report
「The group made total capital investments of ¥48,894 million during the consolidated fiscal year. This amount excludes consumption tax and other taxes. Major projects included expanding electronic-materials production facilities at the Shiga Plant, increasing pharmaceutical production capacity at Kaneka Eurogentec S.A., and expanding electronic-materials production facilities at Tochigi Kaneka Co., Ltd.」
Capital investment totaled ¥48,894 million, with continued investment in the earnings base focused on electronic-materials and pharmaceutical production facilities. - FY2019-Q3AdvancedAnnual report
「The company carried out manufacturing-capacity enhancement projects, including seismic reinforcement work and cogeneration equipment upgrades.」
The company made specific capital investments to strengthen manufacturing capacity, including seismic reinforcement work and cogeneration equipment upgrades. - FY2019-Q2AdvancedAnnual report
「Net cash used in investing activities during the first six months of the current consolidated cumulative period was ¥22,004 million, up ¥2,540 million year on year. The main component was ¥20,006 million in payments for the acquisition of property, plant and equipment.」
The company spent ¥20,006 million on the acquisition of property, plant and equipment in the first six months and continued building up capital investment in its earnings base. - FY2018-Q3AdvancedAnnual report
「Cash flow from investing activities for the cumulative third quarter of the current consolidated period was an outflow of ¥29,442 million, an increase of ¥836 million year on year. The main component was ¥25,067 million in spending on the acquisition of property, plant and equipment.」
The company continued capital investment in its domestic and overseas earnings base, with payments for the acquisition of property, plant and equipment totaling ¥25,067 million. - FY2018-Q2AdvancedAnnual report
「Net cash used in investing activities during the first six months of the current consolidated cumulative period was ¥19,463 million, down ¥868 million year on year. The main component was ¥16,146 million in payments for the acquisition of property, plant and equipment.」
The company spent ¥16,146 million on the acquisition of property, plant and equipment in the first half and continued capital investment to strengthen its earnings base. - FY2018-Q1AdvancedAnnual report
「Net cash used in investing activities during the first quarter of the current consolidated cumulative period was ¥9,842 million, down ¥1,252 million year on year. The main component was ¥8,732 million in payments for the acquisition of property, plant and equipment.」
The company spent ¥8,732 million on the acquisition of property, plant and equipment in the first quarter and continued investing in its domestic and overseas earnings base. - FY2017AdvancedAnnual report
「The group has invested in Japan and overseas to strengthen its earnings base over the medium to long term, and made total capital investments of ¥37,980 million during the consolidated fiscal year. This amount excludes consumption tax and other taxes.」
The company made ¥37,980 million in capital investments, with major projects including expansion of Malaysian production facilities for functional resins and construction of new facilities for modified silicone polymers. - FY2016First statedAnnual report
「The group has invested in Japan and overseas to strengthen its earnings base over the medium to long term, and made total capital investments of ¥40,454 million during the consolidated fiscal year.」
The company disclosed capital investment and major investment projects for the consolidated fiscal year to strengthen its earnings base.